Sunosi interacts with some other drugs. Examples include certain antidepressants, stimulants, and decongestants. An interaction occurs when one substance causes another substance to have a ...

Axsome Therapeutics’ AXSM Auvelity (AXS-05) was launched in the United States in 2022 for the treatment of major depressive disorder (MDD), making it the first approved drug in the company’s portfolio ...

And while there are many medications out there to help people cope with pain, they can often cause their own headaches, to say the very least. Now a pharmaceutical company is potentially on the ...

Jazz Pharmaceuticals ( NASDAQ:JAZZ ), a leading player in the narcolepsy market, is expanding its reach into other markets ...

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

Axsome acquired Sunosi from Jazz Pharmaceuticals ... Axsome had already submitted an application to the U.S. Food and Drug Administration (FDA) for AXS-07, but the agency declined to give it ...